Pilot-scale nucleic acid synthesizer system and pilot-scale nucleic acid synthesizer equipment
By designing a compact pilot-level nucleic acid synthesizer system, the problems of complex structure and high cost of traditional nucleic acid synthesizers are solved, and the production needs of low-cost and efficient pilot line are achieved, and the diversified needs of nucleic acid synthesizers are met.
Patent Information
- Application Number
- CN202420643510.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-29
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2034-03-29
AI Technical Summary
The traditional large-scale production trial-level nucleic acid synthesizer has a complex structure, is inconvenient to install, the detector has a slow response speed and high cost, making it difficult to meet the diversified needs of the pilot line.
A pilot-level nucleic acid synthesizer system was designed, using single-unit pipeline units and reagent pipeline units, including multiple valve groups, pumps, switching valves, detectors and sensors. The overall structure is compact, the pipeline is short, and multiple uses The valve block assembly structure reduces liquid residue and system volume, increasing flexibility and scalability.
It achieves a compact overall structure, low cost, and meets the production needs of pilot lines, reduces the pipeline stock of reagents during the synthesis process, and improves production efficiency and equipment flexibility.
Smart Images

Figure CN222119199U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of nucleic acid synthesizers, in particular to a pilot-level nucleic acid synthesizer system and equipment. Background Art
[0002] With the rapid development of oligonucleotide chain synthesis technology, the synthesis cost has been continuously reduced, and the synthesis length and precision have been continuously improved, making large-scale DNA and RNA synthesis starting from oligonucleotide chains possible. Therefore, nucleic acid synthesizers have emerged. They are used in the biopharmaceutical field and traditional and biopharmaceutical companies engaged in nucleic acid-related research and development.
[0003] Traditional large-scale production pilot-level nucleic acid synthesizers have complex structures, are inconvenient to install, have slow response speeds for their detectors, and have high overall production costs. They are difficult to apply to pilot lines and cannot meet the diverse needs of customers. Utility Model Content
[0004] Therefore, the technical problem to be solved by the utility model is to overcome the problems that the nucleic acid synthesizer in the prior art has a complex structure, high cost, and is difficult to meet the production needs of the pilot line.
[0005] In order to solve the above technical problems, the utility model provides a pilot-scale nucleic acid synthesizer system, comprising:
[0006] A monomer pipeline unit, the monomer pipeline unit comprises a first inlet valve group, a monomer pump, a first switching valve, a column position valve, a UV detector and an outlet valve, the two ends of the monomer pump are respectively connected to the first inlet valve group and the first switching valve, the output end of the first switching valve is connected to the column position valve, the output end of the column position valve is connected to the UV detector, and the output end of the UV detector is connected to the outlet valve; a first pressure sensor and a first flow meter are arranged between the monomer pump and the first switching valve, a first temperature sensor and a second pressure sensor are arranged at the input end of the column position valve, and a third pressure sensor is arranged at the output end of the column position valve; a second temperature sensor and a conductivity meter are arranged between the UV detector and the outlet valve;
[0007] A reagent piping unit, the reagent piping unit includes a second inlet valve group and a circulation pump, the two ends of the circulation pump are respectively connected to the second inlet valve group and the input end of the first switching valve, and a fourth pressure sensor and a second flow meter are arranged between the circulation pump and the first switching valve.
[0008] In one embodiment of the present invention, at least two first inlet valve groups are provided, and a second switching valve is provided between at least two first inlet valve groups and the monomer pump.
[0009] In one embodiment of the present invention, an expansion valve is further provided between the second switching valve and the monomer pump.
[0010] In one embodiment of the present invention, the single pipeline unit further includes an exchanger, and the exchanger is arranged between the first switching valve and the column position valve.
[0011] In one embodiment of the present invention, the reagent pipeline unit further includes a multi-channel proportional valve, and the multi-channel proportional valve is arranged between the second inlet valve group and the circulation pump.
[0012] In one embodiment of the present invention, the output end of the multi-channel proportional valve is also connected to the outlet valve.
[0013] In one embodiment of the present invention, the first inlet valve group, the second inlet valve group and the outlet valve group are all diaphragm valves.
[0014] A pilot-scale nucleic acid synthesizer device comprises the pilot-scale nucleic acid synthesizer system, and also comprises a support frame and an electric control cabinet, wherein the monomer pipeline unit and the reagent pipeline unit are arranged in the support frame, and the electric control cabinet is arranged on the top of the support frame, and the electric control cabinet is electrically connected to the monomer pipeline unit and the reagent pipeline unit.
[0015] In one embodiment of the utility model, rollers and adjustable feet are provided at the bottom of the support frame.
[0016] The above technical solution of the utility model has the following advantages compared with the prior art:
[0017] The utility model discloses a pilot-scale nucleic acid synthesizer system and equipment. First, the first inlet valve group and the second inlet valve group adopt a structure assembled from multiple valve blocks. The overall structure is compact, the liquid pipe diameter is small, the pipeline is short, and the total volume is small, which reduces the inventory of reagents in the pipeline during the synthesis process. The overall production cost is low and meets the needs of pilot line production. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] In order to make the content of the utility model easier to understand, the utility model is further described in detail according to the specific embodiments of the utility model in combination with the accompanying drawings, wherein
[0019] Figure 1 It is a schematic diagram of the overall structure of the utility model;
[0020] Figure 2 It is the synthetic pipeline diagram in the utility model;
[0021] Figure 3 It is a schematic diagram of part of the synthesis pipeline in the utility model;
[0022] Figure 4 It is an operation flow chart of the utility model;
[0023] Explanation of the markings in the specification: 1. Monomer piping unit; 2. Reagent piping unit; 3. Support frame; 4. Electric control cabinet; 5. Roller; 6. Adjustment foot; 101. First inlet valve group; 102. Second switching valve; 103. Expansion valve; 104. Monomer pump; 105. First pressure sensor; 106. First flow meter; 107. First switching valve; 108. Exchanger; 109. First temperature sensor; 110. Second pressure sensor; 111. Column position valve; 112. Third pressure sensor; 113. UV detector; 114. Second temperature sensor; 115. Conductivity meter; 116. Outlet valve; 201. Second inlet valve group; 202. Multi-channel proportional valve; 203. Circulation pump; 204. Fourth pressure sensor; 205. Second flow meter. DETAILED DESCRIPTION
[0024] The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.
[0025] Reference Figure 1-Figure 4 As shown, the utility model discloses a pilot-scale nucleic acid synthesizer system, comprising:
[0026] A monomer pipeline unit 1, the monomer pipeline unit 1 comprises a first inlet valve group, a monomer pump 104, a first switching valve 107, a column valve 111, a UV detector 113 and an outlet valve 116, the two ends of the monomer pump 104 are respectively connected to the first inlet valve group and the first switching valve 107, the output end of the first switching valve 107 is connected to the column valve 111, the output end of the column valve 111 is connected to the UV detector 113, and the output end of the UV detector 113 is connected to the outlet valve 116; a first pressure sensor 105 and a first flow meter 106 are arranged between the monomer pump 104 and the first switching valve 107, a first temperature sensor 109 and a second pressure sensor 110 are arranged at the input end of the column valve 111, and a third pressure sensor 112 is arranged at the output end of the column valve 111; a second temperature sensor 114 and a conductivity meter 115 are arranged between the UV detector and the outlet valve 116;
[0027] The reagent piping unit 2 includes a second inlet valve group 201 and a circulation pump 203. The two ends of the circulation pump 203 are respectively connected to the second inlet valve group 201 and the input end of the first switching valve 107. A fourth pressure sensor 204 and a second flow meter 205 are arranged between the circulation pump 203 and the first switching valve 107.
[0028] It can be seen that the pilot-scale nucleic acid synthesizer system in the utility model is divided into a monomer pipeline unit 1 and a reagent pipeline unit 2. Specifically, the monomer solution passes through the first inlet valve group, and the liquid is pumped into the system by the monomer pump 104: it flows into the first switching valve 107 through the first pressure sensor 105 and the first flowmeter 106. The first switching valve 107 is used to switch the monomer pipeline and the circulation pipeline online at any time according to the production process requirements. The first flowmeter 106 monitors the flow of the monomer pipeline in real time and feeds back the real-time data to the control system. The first pressure sensor 105 monitors the pressure of the monomer pipeline and can also protect the pump from overpressure and stop the pump. The liquid flows into the column valve 111 through the first temperature sensor 109 and the second pressure sensor 110, and is discharged from the outlet valve 116 after passing through the third pressure sensor 112, the UV detector 113, the second temperature sensor 114 and the conductivity detector.
[0029] The reagent solution is pumped into the reagent pipeline by the circulation pump 203 through the second inlet valve group 201: and flows into the first switching valve 107 through the fourth pressure sensor 204 and the second flow meter 205; specifically, the fourth pressure sensor 204 is used to monitor the reagent pump reagent pipeline pressure and is also used to protect the pump from overpressure and stop the pump. The second flow meter 205 monitors the reagent pipeline in real time and feeds back real-time data to the system. The first switching valve 107 can switch between the monomer pipeline and the reagent pipeline at any time. The liquid first temperature sensor 109 and the second pressure sensor 110 flow into the column position valve 111, and then passes through the fourth pressure sensor 204, the UV detector 113, the second temperature sensor 114 and the conductivity detector, and is discharged from the outlet valve 116.
[0030] The multiple temperature sensors and pressure sensors mentioned above can detect changes in temperature and pressure. The UV detector 113 can detect in real time whether the absorbance value of the solution after the nucleic acid column is within the normal range. The conductivity detector can detect in real time whether the conductivity value of the entire system pipeline after cleaning is within the detection range.
[0031] As a preferred embodiment of the utility model, the first inlet valve group and the second inlet valve group 201 adopt a structure of assembling multiple valve blocks, which can reduce the residual liquid inside the valve block, save the use space, and enhance the performance of the entire system. The remaining valve groups are to merge multiple valves into a multi-channel valve block, which greatly saves the use space, reduces a large amount of medium residue, and is easy to clean and maintain. Secondly, the first temperature sensor 109 and the second pressure sensor 110 are assembled on a two-position circulation pool, which can realize centralized monitoring of temperature and pressure, realize flexible expansion of the nucleic acid synthesizer, shorten the length of the flow path pipeline, reduce the volume inside the circulation pool, and minimize the flow path volume of the entire system.
[0032] The first inlet valve group and the second inlet valve group 201 in the utility model adopt a structure assembled from multiple valve blocks, with a compact overall structure, a small liquid pipe diameter, a short pipeline, and a small total volume, which reduces the inventory of reagents in the pipeline during the synthesis process, and the overall production cost is low, meeting the needs of pilot line production.
[0033] Furthermore, at least two groups of the first inlet valve groups are provided, and a second switching valve 101 (first inlet valve group; 102) is provided between the at least two groups of the first inlet valve groups and the monomer pump 104.
[0034] Specifically, multiple groups of first inlet valve groups are set according to process requirements to select the inlet of the monomer pipeline, and then the second switching valve 101 is set to the first inlet valve group; 102 is used to switch between different first inlet valve groups.
[0035] Furthermore, an expansion valve 103 is further provided between the first inlet valve group 102 of the second switching valve 101 and the monomer pump 104 .
[0036] Specifically, after the monomer solution enters the first inlet valve, the expansion valve 103 controls and regulates the fluid path, and the flow and mixing of various reagents need to be precisely controlled to ensure the efficiency, safety and reliability of the nucleic acid synthesis process.
[0037] Furthermore, the monomer pipeline unit 1 further includes an exchanger 108 , and the exchanger 108 is disposed between the first switching valve 107 and the column valve 111 .
[0038] Specifically, the exchanger 108 is an option for the entire system and is used for the transfer of reagents and raw materials. The nucleic acid synthesizer requires various reagents and raw materials to synthesize nucleic acids. The exchanger 108 can ensure that these reagents and raw materials are accurately transferred during the synthesis process, thereby ensuring the quality and efficiency of the synthesis. Secondly, the temperature is regulated. Nucleic acid synthesis needs to be carried out under specific temperature conditions. The exchanger 108 may participate in the temperature regulation to ensure that the reaction is carried out at an appropriate temperature, thereby optimizing the synthesis effect. Finally, the exchanger 108 can also realize the discharge of waste: during the nucleic acid synthesis process, some waste or by-products will be generated. The exchanger 108 can assist in the discharge of these wastes to prevent them from having a negative impact on the synthesis process.
[0039] Furthermore, the reagent pipeline unit 2 also includes a multi-channel proportional valve 202 , which is disposed between the second inlet valve group 201 and the circulation pump 203 ; the output end of the multi-channel proportional valve 202 is also connected to the outlet valve 116 .
[0040] Furthermore, the multi-channel proportional valve 202 is arranged between the second inlet valve group 201 and the circulation pump 203. When the reagent solution is input from the second inlet valve group 201, the flow rate is changed by changing the opening of the multi-channel proportional valve 202 in cooperation with the circulation pump 203. Secondly, the multi-channel proportional valve 202 can select the corresponding output port according to the process requirements.
[0041] Further, as a preferred solution of the present invention, the first inlet valve group, the second inlet valve group 201 and the outlet valve group 116 are all diaphragm valves.
[0042] It should be noted that in the actual operation process, the reagents required for synthesis in each pipeline are all organic solutions, which are volatile and produce toxic gases. Therefore, as a preferred solution of the utility model, each valve is equipped with position feedback of explosion-proof function, and the explosion-proof type is intrinsically safe, which improves the safety of the entire equipment.
[0043] Embodiment 2
[0044] Reference Figure 1 As shown, a pilot-scale nucleic acid synthesizer device includes the pilot-scale nucleic acid synthesizer system described in Example 1, and also includes a support frame 3 and an electric control cabinet 4. The monomer pipeline unit 1 and the reagent pipeline unit 2 are arranged in the support frame 3, and the electric control cabinet 4 is arranged on the top of the support frame 3, and the electric control cabinet 4 is electrically connected to the monomer pipeline unit 1 and the reagent pipeline unit 2.
[0045] Similarly, in order to ensure the safety of the entire equipment, the electric control cabinet 4 in the utility model has a single-sided double door and has an explosion-proof function, and the explosion-proof type is a positive pressure type. Secondly, the system is also equipped with a remote control box and a mobile control platform. The remote control box can be placed in a safe area to remotely control the system. When the system needs repair or maintenance, the mobile control platform can be pushed into the explosion-proof room for operation, and then pushed back to the safe area for operation.
[0046] Specifically, the support frame 3 supports the installation of various components, facilitates the layout of the entire pipeline and the integration of valve group components, and reduces the overall installation size. Specifically, the electric control cabinet 4 is electrically connected to the single pipeline unit 1 and various components in the pipeline unit, on the one hand, for feedback of real-time data monitored by each detection component, and on the other hand, for automatic control of each valve group.
[0047] Furthermore, the bottom of the support frame 3 is provided with rollers 5 and adjustable feet 6. Specifically, the rollers 5 are installed at the bottom of the support frame 3 to facilitate the transportation of the entire equipment, and the adjustable feet 6 can ensure the stability of the equipment after it is fixed, avoiding shaking during the synthesis process to affect the synthesis effect.
[0048] In summary, the utility model introduces a pilot-level nucleic acid synthesizer system and equipment, and the specific process is as follows: the monomer solution passes through the first inlet valve group, the switching valve and the expansion valve 103, and the liquid is pumped into the system by the monomer pump 104: it flows into the first switching valve 107 through the first pressure sensor 105 and the first flowmeter 106. The first switching valve 107 is used to switch the monomer pipeline and the circulation pipeline online at any time according to the production process requirements. The first flowmeter 106 monitors the flow of the monomer pipeline in real time and feeds back the real-time data to the control system. The first pressure sensor 105 monitors the pressure of the monomer pipeline and can also protect the pump from overpressure and stop the pump. The liquid flows into the column valve 111 through the first temperature sensor 109 and the second pressure sensor 110, and is discharged from the outlet valve 116 after passing through the third pressure sensor 112, the UV detector 113, the second temperature sensor 114 and the conductivity detector. The reagent solution is pumped into the reagent pipeline by the circulation pump 203 through the second inlet valve group 201: it flows into the first switching valve 107 through the fourth pressure sensor 204 and the second flow meter 205; specifically, the fourth pressure sensor 204 is used to monitor the reagent pump reagent pipeline pressure and is also used to protect the pump from overpressure and stop the pump. The second flow meter 205 monitors the reagent pipeline in real time and feeds back or controls the system with real-time data. The first switching valve 107 can switch between the monomer pipeline and the reagent pipeline at any time. The liquid first temperature sensor 109 and the second pressure sensor 110 flow into the column valve 111, and then passes through the third pressure sensor 112, UV detector 113, second temperature sensor 114 and conductivity detector, and is discharged from the outlet valve 116. The first inlet valve group and the second inlet valve group 201 in the utility model adopt a structure assembled by multiple valve blocks, with a compact overall structure, a small liquid pipe diameter, a short pipeline, and a small total volume. The entire production cost is low, meeting the needs of pilot line production.
[0049] Obviously, the above embodiments are merely examples for the purpose of clear explanation and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived therefrom are still within the scope of protection of the invention of the utility model.
Claims
1. A pilot-scale nucleic acid synthesizer system, characterized in that: include: A monomer pipeline unit, the monomer pipeline unit comprises a first inlet valve group, a monomer pump, a first switching valve, a column position valve, a UV detector and an outlet valve, the two ends of the monomer pump are respectively connected to the first inlet valve group and the first switching valve, the output end of the first switching valve is connected to the column position valve, the output end of the column position valve is connected to the UV detector, and the output end of the UV detector is connected to the outlet valve; a first pressure sensor and a first flow meter are arranged between the monomer pump and the first switching valve, a first temperature sensor and a second pressure sensor are arranged at the input end of the column position valve, and a third pressure sensor is arranged at the output end of the column position valve; a second temperature sensor and a conductivity meter are arranged between the UV detector and the outlet valve; A reagent piping unit, the reagent piping unit includes a second inlet valve group and a circulation pump, the two ends of the circulation pump are respectively connected to the second inlet valve group and the input end of the first switching valve, and a fourth pressure sensor and a second flow meter are arranged between the circulation pump and the first switching valve.
2. The pilot-scale nucleic acid synthesizer system according to claim 1, characterized in that: At least two first inlet valve groups are provided, and a second switching valve is provided between at least two first inlet valve groups and the monomer pump.
3. The pilot-scale nucleic acid synthesizer system according to claim 2, characterized in that: An expansion valve is further provided between the second switching valve and the monomer pump.
4. The pilot-scale nucleic acid synthesizer system according to claim 1, characterized in that: The single pipeline unit further includes an exchanger, and the exchanger is arranged between the first switching valve and the column valve.
5. The pilot-scale nucleic acid synthesizer system according to claim 1, characterized in that: The reagent pipeline unit further comprises a multi-channel proportional valve, and the multi-channel proportional valve is arranged between the second inlet valve group and the circulation pump.
6. The pilot-scale nucleic acid synthesizer system according to claim 5, characterized in that: The output end of the multi-channel proportional valve is also communicated with the outlet valve.
7. The pilot-scale nucleic acid synthesizer system according to claim 5, characterized in that: The first inlet valve group, the second inlet valve group and the outlet valve group are all diaphragm valves.
8. A pilot-scale nucleic acid synthesizer device, comprising the pilot-scale nucleic acid synthesizer system according to any one of claims 1 to 7, characterized in that: It also includes a support frame and an electric control cabinet. The monomer pipeline unit and the reagent pipeline unit are arranged in the support frame. The electric control cabinet is arranged on the top of the support frame, and the electric control cabinet is electrically connected to the monomer pipeline unit and the reagent pipeline unit.
9. The pilot-scale nucleic acid synthesizer device according to claim 8, characterized in that: The bottom of the support frame is provided with rollers and adjusting feet.
